首页> Frontiers in immunology> Tumor heterogeneity assessment using single-cell RNA sequencing (scRNA-seq): applications in lung cancer for diagnosis and treatment.

Tumor heterogeneity assessment using single-cell RNA sequencing (scRNA-seq): applications in lung cancer for diagnosis and treatment.

导出 LinkOut

翻译打印收藏纠错

第一作者： Cecilia,Bica

第一单位： Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

作者： Cecilia,Bica ^[1] ; Oana,Zanoaga ^[1] ; Laura,Pop ^[1] ; Cristina,Ciocan ^[1] ; Lajos,Raduly ^[1] ; Andreea,Nuțu ^[1] ; Ioana,Berindan-Neagoe ^[2] ; Andreas,Bender ^[3]

作者单位： Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. ^[1] Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.;Doctoral School, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.;Romanian Academy of Medical Sciences, Bucharest, Romania. ^[2] Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.;College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.;Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Cambridge, United Kingdom.;STAR-UBB Institute, Babeş-Bolyai University, Cluj-Napoca, Romania. ^[3]

关键词 lung cancer molecular profile single-cell RNA sequencing (scRNA-seq)tumor heterogeneity tumor microenvironment (TME)